Home email Your Specialist for Hazardous Reactions. DOTTIKON EXCLUSIVE SYNTHESIS AG manufactures high-quality performance chemicals, intermediates, and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical, biotech, and pharmaceutical industry. More than Hazardous Reactions Exclusive Synthesis of APIs and performance chemicals R&D, routefinding and process development Process intensification under cGMP Multi-ton cGMP production Quality management, FDA and Swissmedic approved Over 105 years of experience in hazardous reactions One-site strategy in Switzerland with more than 600 employees Now hiring Find out more about our jobs and career opportunities © Copyright 2021, DOTTIKON ES HOLDING AG | Privacy Policy

Home > Contact > Investors E | D email Investor Contact Marlene Born investor-relations@dottikon.com Tel +41 56 616 82 01 Fax +41 56 616 89 45 Investor News Service © Copyright 2021, DOTTIKON ES HOLDING AG | Privacy Policy